Clinical Trials Browser

Neurofibromatosis 1 × Pharmacokinetics × Clear all

NCT00727233 2019-12-12

Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

Phase 1 Completed

Neurofibromatosis 1, Neurofibroma, Plexiform